Histone Deacetylases and Their Inhibition in Candida Species
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Fungi are generally benign members of the human mucosal flora or live as saprophytes in the environment. However, they can become pathogenic, leading to invasive and life threatening infections in vulnerable patients. These invasive fungal infections are regarded as a major public health problem on a similar scale to tuberculosis or malaria. Current treatment for these infections is based on only four available drug classes. This limited therapeutic arsenal and the emergence of drug-resistant strains are a matter of concern due to the growing number of patients to be treated, and new therapeutic strategies are urgently needed. Adaptation of fungi to drug pressure involves transcriptional regulation, in which chromatin dynamics and histone modifications play a major role. Histone deacetylases (HDACs) remove acetyl groups from histones and actively participate in controlling stress responses. HDAC inhibition has been shown to limit fungal development, virulence, biofilm formation, and dissemination in the infected host, while also improving the efficacy of existing antifungal drugs toward Candida spp. In this article, we review the functional roles of HDACs and the biological effects of HDAC inhibitors on Candida spp., highlighting the correlations between their pathogenic effects in vitro and in vivo. We focus on how HDAC inhibitors could be used to treat invasive candidiasis while also reviewing recent developments in their clinical evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110 · cited 3×
“One of its key virulence traits is its morphological plasticity; its ability to shift from a yeast form to Frontiers in Microbiology | www.frontiersin.org 1 August 2016 | Volume 7 | Article 1238 a hyphal form has been clearly linked to virulence (Sudbery, 2011; Gow et al., 2012).”
BackgroundBitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002 · cited 1×
“Sirtuin Inhibitors Nicotinamide is a vitamin and precursor of NAD+ and a welldescribed inhibitor of Class III HDACs, including Sir2 (Landry et al., 2000; Bitterman et al., 2002; Sanders et al., 2007).”
BackgroundThe silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., & Sternglanz, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110148297 · Cited by 970
Candida albicans morphogenesis and host defence: discriminating invasion from colonization
Gow, N. A. R., van de Veerdonk, F. L., Brown, A. J. P., & Netea, M. G. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2711 · Cited by 888
A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans
Nobile, C. J., Fox, E. P., Nett, J. E., Sorrells, T. R., Mitrovich, Q. M., Hernday, A. D., Tuch, B. B., Andes, D. R., & Johnson, A. D. (2012) · Cell · doi:10.1016/j.cell.2011.10.048 · Cited by 711
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · cited 2×
“The sirtuins Hst3 and Sir2 were identified as switch repressors, whereas Set3C HDACs (Set3 and Hos2) were recognized as key activators of the white-to-opaque switch (Figure 1) (PérezMartín et al., 1999; Hnisz et al., 2009; Stevenson and Liu, 2011).”
BackgroundHsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 3×
“Hda1 and Rpd3 control the acetylation of Hsp90, a protein involved in the development of drug resistance in various fungi (Cowen and Lindquist, 2005; Robbins et al., 2012).”
BackgroundEntrez Gene: gene-centered information at NCBI
Maglott, D., Ostell, J., Pruitt, K. D., & Tatusova, T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl993 · Cited by 633
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422 · cited 1×
“They are also an important source of antifungal resistance because the extracellular matrix hinders drug diffusion (Taff et al., 2013; Perlin et al., 2015).”
BackgroundEnjalbert, B., Smith, D. A., Cornell, M. J., Alam, I., Nicholls, S., Brown, A. J. P., & Quinn, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0501 · Cited by 381
Roger, T., Lugrin, J., Le Roy, D., Goy, G., Mombelli, M., Koessler, T., Ding, X. C., Chanson, A.-L., Reymond, M. K., Miconnet, I., et al. (2011) · Blood · doi:10.1182/blood-2010-05-284711 · Cited by 341 · cited 2×
“The sirtuins Hst3 and Sir2 were identified as switch repressors, whereas Set3C HDACs (Set3 and Hos2) were recognized as key activators of the white-to-opaque switch (Figure 1) (PérezMartín et al., 1999; Hnisz et al., 2009; Stevenson and Liu, 2011).”
BackgroundInfluentialLiu, T. T., Lee, R. E. B., Barker, K. S., Lee, R. E., Wei, L., Homayouni, R., & Rogers, P. D. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2226-2236.2005 · Cited by 313
Regulation of multidrug resistance in pathogenic fungi
Morschhäuser, J. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.08.002 · Cited by 300 · cited 2×
“With the HAT Rtt109, Hst3 dynamically controls the level of lysine 56 acetylation on histone H3 (Rundlett et al., 1996; Wurtele et al., 2010).”
BackgroundFuchs, B. B., & Mylonakis, E. (2009) · Eukaryotic Cell · doi:10.1128/ec.00193-09 · Cited by 266 · cited 1×
“…2009; Zacchi et al., 2010 Hos3 C4_02300W Q5AF34 Srikantha et al., 2001 III Sirtuin Sir2 C2_01330C O59923 Klar et al., 2001; Maglott et al., 2007; Fu et al., 2008; Nobile et al., 2012 Hst1 C1_09050W Q5AQ47 Maglott et al., 2007; Hnisz et al., 2009 Hst2 CR_01800C Q5A985 Maglott et al., 2007; Hnisz…”
Uhl, M. A., Biery, M., Craig, N., & Johnson, A. D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg256 · Cited by 191
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy
Wurtele, H., Tsao, S., Lépine, G., Mullick, A., Tremblay, J., Drogaris, P., Lee, E.-H., Thibault, P., Verreault, A., & Raymond, M. (2010) · Nature Medicine · doi:10.1038/nm.2175 · Cited by 157
Smith, W. L., & Edlind, T. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3532-3539.2002 · Cited by 147 · cited 7×
“Finally, apicidin, a cyclic tetrapeptide, displays limited direct antifungal activity against C. albicans (Smith and Edlind, 2002).”
BackgroundInfluentialPfaller, M. A., Messer, S. A., Georgopapadakou, N., Martell, L. A., Besterman, J. M., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00618-09 · Cited by 143
Structure of the transcriptional network controlling white‐opaque switching in C andida albicans
Hernday, A. D., Lohse, M. B., Fordyce, P. M., Nobile, C. J., DeRisi, J. L., & Johnson, A. D. (2013) · Molecular Microbiology · doi:10.1111/mmi.12329 · Cited by 131 · cited 2×
“The white-to-opaque transition involves a set of transcription factors responsible for the control of genes specific to white and opaque cells (Hernday et al., 2013).”
BackgroundHnisz, D., Majer, O., Frohner, I. E., Komnenovic, V., & Kuchler, K. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000889 · Cited by 124
Rai, M. N., Balusu, S., Gorityala, N., Dandu, L., & Kaur, R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002863 · Cited by 117 · cited 2×
“Chromatin remodeling and sirtuin-family HDACs are required for C. glabrata to adapt to stressful conditions such as survival inside phagocytes, adhesion and maintenance of colonization, or multidrug resistance (Rai et al., 2012; Orta-Zavalza et al., 2013; De Las Peñas et al., 2015).”
BackgroundSingh, R. P., Prasad, H. K., Sinha, I., Agarwal, N., & Natarajan, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233569 · Cited by 113 · cited 1×
“…relatively low antifungal activity (Mai et al., 2007), although another study showed that the same concentration could reduce the pathogenicity of C. albicans by decreasing its adherence to cultured human cells by 90%, and significantly inhibiting serum-induced germination (Simonetti et al., 2007).”
BackgroundThe Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion
Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., & Lopez-Ribot, J. L. (2010) · Eukaryotic Cell · doi:10.1128/ec.00111-10 · Cited by 110 · cited 1×
“Notably, Nrg1, which is transiently repressed by Set3C during filamentation, is involved in the regulation of cellular dispersion (Uppuluri et al., 2010).”
BackgroundHnisz, D., Bardet, A. F., Nobile, C. J., Petryshyn, A., Glaser, W., Schöck, U., Stark, A., & Kuchler, K. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003118 · Cited by 100
Lu, Y., Su, C., & Liu, H. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002663 · Cited by 92
A Histone Deacetylase Complex Mediates Biofilm Dispersal and Drug Resistance in Candida albicans
Nobile, C. J., Fox, E. P., Hartooni, N., Mitchell, K. F., Hnisz, D., Andes, D. R., Kuchler, K., & Johnson, A. D. (2014) · mBio · doi:10.1128/mbio.01201-14 · Cited by 87
Histone deacetylases in fungi: novel members, new facts
Trojer, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg473 · Cited by 86 · cited 2×
“Three main classes of HDACs have been originally described in C. albicans based on the key S. cerevisiae enzymes (Trojer et al., 2003; Kim et al., 2015).”
BackgroundApoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81 · cited 4×
“Thus, Al-Dhaheri and Douglas (2010) showed that, in the presence of amphotericin B, TSA or apicidin, sodium butyrate significantly reduced viability of Candida spp. in biofilms.”
BackgroundInfluentialPfaller, M. A., Rhomberg, P. R., Messer, S. A., & Castanheira, M. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.11.008 · Cited by 67 · cited 5×
“Moreover, in most azole- or echinocandin-resistant strains, combination with a HDAC inhibitor led to a shift from resistance to greater susceptibility (Pfaller et al., 2015).”
BackgroundResultInfluentialThe Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans
Li, X., Cai, Q., Mei, H., Zhou, X., Shen, Y., Li, D., & Liu, W. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv070 · Cited by 64
Orta‐Zavalza, E., Guerrero‐Serrano, G., Gutiérrez‐Escobedo, G., Cañas‐Villamar, I., Juárez‐Cepeda, J., Castaño, I., & De Las Peñas, A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12247 · Cited by 61
Tscherner, M., Zwolanek, F., Jenull, S., Sedlazeck, F. J., Petryshyn, A., Frohner, I. E., Mavrianos, J., Chauhan, N., von Haeseler, A., & Kuchler, K. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1005218 · Cited by 57 · cited 1×
“…such as acetylation, methylation, and phosphorylation have been shown to play a role in regulating stress responses, antifungal tolerance and virulence in C. albicans and C. glabrata (Liu et al., 2005; Rai et al., 2012; Stevenson and Liu, 2013; Kim et al., 2015; Tscherner et al., 2015).”
BackgroundHistone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans
Simonetti, G., Passariello, C., Rotili, D., Mai, A., Garaci, E., & Palamara, A. T. (2007) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2007.00276.x · Cited by 57
Cited by
Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194
Genetic Drivers of Multidrug Resistance in Candida glabrata
Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93
Shivarathri, R., Tscherner, M., Zwolanek, F., Singh, N. K., Chauhan, N., & Kuchler, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-45817-5 · Cited by 58
Histone Acetylation/Deacetylation in Candida Albicans and their Potential as Antifungal Targets
Su, S., Li, X., Yang, X., Li, Y., Chen, X., Sun, S., & Jia, S. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0343 · Cited by 36
Metadata
- Authors
- Garnaud, C., Champleboux, M., Maubon, D., Cornet, M., & Govin, J.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-08-05
- Volume
- 7
- Pages
- 1238-1238
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2483638857
- Cited by
- 81
- References
- 37
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.